Nuclear Receptor Screening Services and Products

Indigo Biosciences is a preclinical contract research organization, serving clients involved in pharmaceutical R&D, biotechnology, and related sectors. We offer high quality services and products that facilitate drug discovery / drug development, the analysis of active ingredients, and molecular toxicology. We specialize in evaluation of the effects of small molecules on nuclear receptors, a major class of therapeutic drug targets involved in cancer, diabetes, atherosclerosis, obesity, and many other diseases.


  • Industrial Clients:
    • Take advantage of our confidential bioassay screening and preclinical compound profiling services. Our clients maintain title to, ownership of, and all proprietary rights to data provided by Indigo Biosciences. Allow Indigo to complement your strengths by saving you time and money on what we do best. Contact one of our scientists today to discuss your outsourcing needs.


  • Academic Clients:
    • Indigo can speed the acquisition of data for your next publication or grant application. We can rapidly screen your compounds for cytotoxicity, anticancer activity, or interactions with specific receptors. Indigo can help you generate the preliminary data your grant application needs to succeed.


Download our Brochure or visit our Services page.